Ciprofloxacin for Treatment of Tularemia
Open Access
- 15 July 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (2) , 267-268
- https://doi.org/10.1086/321825
Abstract
With respect to new options for the treatment of tularemia, conclusions should be based mainly on results from primary use of a drug. For patients who have prevKeywords
This publication has 9 references indexed in Scilit:
- Evaluation of PCR-Based Methods for Discrimination of Francisella Species and Subspecies and Development of a Specific PCR That Distinguishes the Two Major Subspecies of Francisella tularensisJournal of Clinical Microbiology, 2000
- In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animalsJournal of Antimicrobial Chemotherapy, 2000
- Treatment of Tularemia with CiprofloxacinClinical Infectious Diseases, 2000
- Ciprofloxacin for treatment of tularemia in childrenThe Pediatric Infectious Disease Journal, 2000
- Treatment of Tularemia with Fluoroquinolones: Two Cases and ReviewClinical Infectious Diseases, 1999
- The efficacy of ciprofloxacin and doxycycline against experimental tularaemia.Journal of Antimicrobial Chemotherapy, 1998
- Infrequent Manifestations of Tularaemia in SwedenScandinavian Journal of Infectious Diseases, 1997
- In vitro susceptibility ofFrancisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991